CLRB logo

Cellectar Biosciences (CLRB) Net Income

Annual Net Income

-$42.77 M
-$10.98 M-34.53%

December 31, 2023


Summary


Performance

CLRB Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLRBprofitabilitymetrics:

Quarterly Net Income

-$14.66 M
-$13.75 M-1495.03%

September 30, 2024


Summary


Performance

CLRB Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLRBprofitabilitymetrics:

TTM Net Income

-$50.11 M
+$2.86 M+5.39%

September 30, 2024


Summary


Performance

CLRB TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLRBprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

CLRB Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-34.5%-86.1%-17.1%
3 y3 years-183.4%-152.0%-129.7%
5 y5 years-223.1%-275.6%-255.6%

CLRB Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-77.3%at low-1495.0%+45.0%-109.6%+19.5%
5 y5-year-203.5%at low-1495.0%+45.0%-255.6%+19.5%
alltimeall time-1300.8%at low-374.1%+45.0%-2052.5%+19.5%

Cellectar Biosciences Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$14.66 M(+1495.0%)
-$50.11 M(-5.4%)
Jun 2024
-
-$919.40 K(-96.5%)
-$52.96 M(-14.9%)
Mar 2024
-
-$26.64 M(+238.0%)
-$62.22 M(+45.5%)
Dec 2023
-$42.77 M(+34.5%)
-$7.88 M(-55.0%)
-$42.77 M(-5.6%)
Sep 2023
-
-$17.52 M(+72.1%)
-$45.30 M(+27.3%)
Jun 2023
-
-$10.18 M(+41.6%)
-$35.59 M(+8.4%)
Mar 2023
-
-$7.19 M(-30.9%)
-$32.84 M(+3.3%)
Dec 2022
-$31.79 M(+31.8%)
-$10.41 M(+33.2%)
-$31.79 M(+16.4%)
Sep 2022
-
-$7.81 M(+5.1%)
-$27.30 M(+7.9%)
Jun 2022
-
-$7.43 M(+21.1%)
-$25.31 M(+5.9%)
Mar 2022
-
-$6.14 M(+3.7%)
-$23.91 M(-0.9%)
Dec 2021
-$24.12 M(+59.8%)
-$5.92 M(+1.7%)
-$24.12 M(+10.6%)
Sep 2021
-
-$5.82 M(-3.5%)
-$21.82 M(+9.6%)
Jun 2021
-
-$6.03 M(-5.2%)
-$19.91 M(+13.8%)
Mar 2021
-
-$6.36 M(+75.9%)
-$17.49 M(+15.9%)
Dec 2020
-$15.09 M(+7.1%)
-$3.62 M(-7.5%)
-$15.09 M(+1.6%)
Sep 2020
-
-$3.91 M(+8.2%)
-$14.86 M(+0.0%)
Jun 2020
-
-$3.61 M(-8.7%)
-$14.85 M(+2.9%)
Mar 2020
-
-$3.96 M(+17.1%)
-$14.43 M(+2.4%)
Dec 2019
-$14.09 M(+6.4%)
-$3.38 M(-13.4%)
-$14.09 M(-3.1%)
Sep 2019
-
-$3.90 M(+22.5%)
-$14.54 M(+6.5%)
Jun 2019
-
-$3.19 M(-12.0%)
-$13.65 M(+2.0%)
Mar 2019
-
-$3.62 M(-5.4%)
-$13.38 M(+1.1%)
Dec 2018
-$13.24 M(-2.4%)
-$3.83 M(+27.0%)
-$13.24 M(-1.9%)
Sep 2018
-
-$3.01 M(+3.2%)
-$13.49 M(-3.3%)
Jun 2018
-
-$2.92 M(-16.0%)
-$13.95 M(-1.4%)
Mar 2018
-
-$3.48 M(-14.8%)
-$14.15 M(+4.3%)
Dec 2017
-$13.56 M(+119.4%)
-$4.08 M(+17.5%)
-$13.56 M(+12.4%)
Sep 2017
-
-$3.47 M(+11.2%)
-$12.07 M(+10.9%)
Jun 2017
-
-$3.12 M(+8.0%)
-$10.88 M(+10.0%)
Mar 2017
-
-$2.89 M(+11.8%)
-$9.90 M(+60.1%)
Dec 2016
-$6.18 M(+12.5%)
-$2.59 M(+13.0%)
-$6.18 M(+133.7%)
Sep 2016
-
-$2.29 M(+7.2%)
-$2.64 M(+19.3%)
Jun 2016
-
-$2.13 M(-358.7%)
-$2.22 M(-6.5%)
Mar 2016
-
$824.60 K(-13.3%)
-$2.37 M(-56.9%)
Dec 2015
-$5.50 M(-31.8%)
$950.90 K(-151.2%)
-$5.50 M(-43.9%)
Sep 2015
-
-$1.86 M(-18.7%)
-$9.79 M(+28.7%)
Jun 2015
-
-$2.29 M(-0.6%)
-$7.61 M(+2.7%)
Mar 2015
-
-$2.30 M(-31.2%)
-$7.41 M(-8.0%)
DateAnnualQuarterlyTTM
Dec 2014
-$8.05 M(-25.3%)
-$3.35 M(-1133.0%)
-$8.05 M(-7.0%)
Sep 2014
-
$324.00 K(-115.5%)
-$8.65 M(-15.9%)
Jun 2014
-
-$2.09 M(-29.1%)
-$10.29 M(+0.2%)
Mar 2014
-
-$2.94 M(-25.5%)
-$10.27 M(-4.7%)
Dec 2013
-$10.78 M(+22.6%)
-$3.95 M(+200.2%)
-$10.78 M(+19.9%)
Sep 2013
-
-$1.32 M(-36.3%)
-$8.99 M(-7.6%)
Jun 2013
-
-$2.06 M(-40.2%)
-$9.73 M(-1.7%)
Mar 2013
-
-$3.45 M(+60.1%)
-$9.89 M(+12.5%)
Dec 2012
-$8.80 M(+18.3%)
-$2.16 M(+5.1%)
-$8.80 M(+2.2%)
Sep 2012
-
-$2.05 M(-8.0%)
-$8.61 M(+1.7%)
Jun 2012
-
-$2.23 M(-5.4%)
-$8.46 M(-4.1%)
Mar 2012
-
-$2.36 M(+19.9%)
-$8.83 M(+18.7%)
Dec 2011
-$7.44 M(+63.0%)
-$1.97 M(+3.0%)
-$7.44 M(+25.4%)
Sep 2011
-
-$1.91 M(-26.4%)
-$5.93 M(+25.6%)
Jun 2011
-
-$2.60 M(+168.8%)
-$4.72 M(+26.0%)
Mar 2011
-
-$965.30 K(+109.0%)
-$3.75 M(-246.1%)
Dec 2010
-$4.56 M(-79.5%)
-$461.80 K(-34.0%)
$2.57 M(-126.1%)
Sep 2010
-
-$700.20 K(-56.8%)
-$9.83 M(-17.2%)
Jun 2010
-
-$1.62 M(-130.3%)
-$11.88 M(-21.4%)
Mar 2010
-
$5.35 M(-141.6%)
-$15.11 M(-32.2%)
Dec 2009
-$22.27 M(+35.4%)
-$12.86 M(+368.8%)
-$22.27 M(+92.8%)
Sep 2009
-
-$2.74 M(-43.5%)
-$11.55 M(+1.8%)
Jun 2009
-
-$4.86 M(+167.8%)
-$11.34 M(+1.6%)
Mar 2009
-
-$1.81 M(-15.2%)
-$11.16 M(-32.1%)
Dec 2008
-$16.45 M(-15.9%)
-$2.14 M(-15.6%)
-$16.45 M(-21.1%)
Sep 2008
-
-$2.53 M(-45.8%)
-$20.85 M(-15.7%)
Jun 2008
-
-$4.68 M(-34.1%)
-$24.73 M(+1.9%)
Mar 2008
-
-$7.10 M(+8.6%)
-$24.28 M(+24.1%)
Dec 2007
-$19.56 M(+136.0%)
-$6.54 M(+1.9%)
-$19.56 M(+24.6%)
Sep 2007
-
-$6.41 M(+52.0%)
-$15.69 M(+29.9%)
Jun 2007
-
-$4.22 M(+77.3%)
-$12.08 M(+29.7%)
Mar 2007
-
-$2.38 M(-10.9%)
-$9.31 M(+12.4%)
Dec 2006
-$8.29 M(+171.4%)
-$2.67 M(-4.6%)
-$8.29 M(+31.1%)
Sep 2006
-
-$2.80 M(+92.2%)
-$6.32 M(+41.3%)
Jun 2006
-
-$1.46 M(+7.6%)
-$4.47 M(+11.9%)
Mar 2006
-
-$1.35 M(+92.1%)
-$4.00 M(+30.9%)
Dec 2005
-$3.05 M
-$704.90 K(-26.2%)
-$3.05 M(+30.0%)
Sep 2005
-
-$954.90 K(-2.8%)
-$2.35 M(+68.5%)
Jun 2005
-
-$982.90 K(+139.3%)
-$1.39 M(+239.3%)
Mar 2005
-
-$410.70 K
-$410.70 K

FAQ

  • What is Cellectar Biosciences annual net profit?
  • What is the all time high annual net income for Cellectar Biosciences?
  • What is Cellectar Biosciences annual net income year-on-year change?
  • What is Cellectar Biosciences quarterly net profit?
  • What is the all time high quarterly net income for Cellectar Biosciences?
  • What is Cellectar Biosciences quarterly net income year-on-year change?
  • What is Cellectar Biosciences TTM net profit?
  • What is the all time high TTM net income for Cellectar Biosciences?
  • What is Cellectar Biosciences TTM net income year-on-year change?

What is Cellectar Biosciences annual net profit?

The current annual net income of CLRB is -$42.77 M

What is the all time high annual net income for Cellectar Biosciences?

Cellectar Biosciences all-time high annual net profit is -$3.05 M

What is Cellectar Biosciences annual net income year-on-year change?

Over the past year, CLRB annual net profit has changed by -$10.98 M (-34.53%)

What is Cellectar Biosciences quarterly net profit?

The current quarterly net income of CLRB is -$14.66 M

What is the all time high quarterly net income for Cellectar Biosciences?

Cellectar Biosciences all-time high quarterly net profit is $5.35 M

What is Cellectar Biosciences quarterly net income year-on-year change?

Over the past year, CLRB quarterly net profit has changed by -$6.78 M (-86.07%)

What is Cellectar Biosciences TTM net profit?

The current TTM net income of CLRB is -$50.11 M

What is the all time high TTM net income for Cellectar Biosciences?

Cellectar Biosciences all-time high TTM net profit is $2.57 M

What is Cellectar Biosciences TTM net income year-on-year change?

Over the past year, CLRB TTM net profit has changed by -$7.34 M (-17.15%)